Delphi specializes in the biotechnology space with an emphasis on genomic and proteomic companies.  Our clients range from small to large corporations that are looking to do one, or a combination of the following:

• Acquire new technologies or expand current product offerings into new markets
• Establish business relationships in new markets
• Develop strategies for new product(s) launch
• Identify target markets in which their product(s) have a unique competitive advantage and develop strategic and tactical market plan
• Develop a new value proposition to position themselves against the competition in markets in which they currently compete
• Update current branding or marketing material

Utilizing our proprietary financial models, in-depth market knowledge and access to thought leaders, Delphi will provide more than just market numbers, we will actually interpret the meaning of those numbers and provide an action plan. Our expertise is within, but not limited to, the following markets:

• Proteomic Platforms and Reagents: Including antibodies, assays and protein arrays
• Genomic Platforms and Reagents: Including gene expression (digital and qualitative), sequencing (specializing in next generation platforms), methylation, SNPs, CNVs, candidate capture technologies and fine mapping
• Consumer Genomics
• Analysis of genetic projects and help choosing the appropriate instrumentation/solution